✨
AI Summary
- Seth Ettenberg discusses BlueRock's Parkinson's trial.
- Promising therapeutic applications for iPSCs in development.
- Major regulatory challenges and future progress for iPSCs.
Guests on This Episode
SE
Seth Ettenberg
1 podcast appearance